<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31924826</article-id><article-id pub-id-type="pmc">6954254</article-id><article-id pub-id-type="publisher-id">56874</article-id><article-id pub-id-type="doi">10.1038/s41598-019-56874-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>25-vitamin D reduces inflammation in uremic environment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Brito</surname><given-names>Rodrigo Barbosa de Oliveira</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rebello</surname><given-names>Jacqueline Ferritto</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Grabulosa</surname><given-names>Caren Cristina</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pinto</surname><given-names>Walter</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8817-6227</contrib-id><name><surname>Morales</surname><given-names>Armando</given-names><suffix>Jr.</suffix></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Elias</surname><given-names>Rosilene Motta</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7902-2127</contrib-id><name><surname>Moyses</surname><given-names>Rosa Maria Affonso</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9282-7181</contrib-id><name><surname>Dalboni</surname><given-names>Maria Aparecida</given-names></name><address><email>dalboni@uni9.pro.br</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0414 8221</institution-id><institution-id institution-id-type="GRID">grid.412295.9</institution-id><institution>Universidade Nove de Julho, UNINOVE, </institution></institution-wrap>Sao Paulo, Brazil </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0722</institution-id><institution-id institution-id-type="GRID">grid.11899.38</institution-id><institution>Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, </institution></institution-wrap>Sao Paulo, Brazil </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>10</volume><elocation-id>128</elocation-id><history><date date-type="received"><day>20</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>23</day><month>9</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Chronic kidney disease (CKD) is characterized by loss of renal function and a consequent increase of serum uremic toxins, which contribute to inflammation status. Deficiency of 25-vitamin D, often found in patients with CKD, has been included as an inflammatory factor since it might modulate the immune system. The aim of this study was to investigate the role of 25-vitamin D on inflammatory pathways in healthy and uremic environment. Toll-like receptor 4 (TLR4), oxidative stress (ROS), vitamin D receptor (VDR), 1-&#x003b1; hydroxylase (CYP27), 24 hydroxylase, cathelicidin, and MCP-1 were evaluated in monocytes exposed to a uremic serum pool compared with healthy pool. The human monocytes lineage (U937) was incubated with or without 25-vitamin D (50&#x02009;ng/ml for 24&#x02009;hours). TRL4, VDR, CYP27, CYP24, and ROS were evaluated by flow cytometry. We used ELISA to measure IL-6, TNF-&#x003b1;, IL-10, cathelicidin, and MCP-1 in the cell culture supernatant. We observed a higher expression of TRL-4, IL-6, TNF-&#x003b1;, IL-10, cathelicidin and MCP-1 in monocytes incubated with uremic serum when compared with serum from healthy individuals. Supplementation of 25-vitamin D was able to reduce the expression of TRL4, cathelicidin, and MCP-1 in the uremic environment. There was no difference in the expression of VDR, CYP27 and CYP24 intracellular enzymes. This <italic>in vitro</italic> study showed that the uremic pool activates inflammatory response in monocytes, which was reversed by 25-vitamin D supplementation; this finding suggests that 25-vitamin D has an anti-inflammatory role in the uremic environment.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Applied immunology</kwd><kwd>Haemodialysis</kwd></kwd-group><funding-group><award-group><funding-source><institution>Funda&#x000e7;&#x000e3;o de Amparo a Pesquisa do Estado de S&#x000e3;o Paulo - FAPESP 2014/14192-1</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Chronic Kidney disease (CKD) is characterized by the loss of glomerular filtration rate resulting in serum accumulation of toxic substances, called uremic toxins<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. The accumulation of these compounds is defined as the uremic environment.</p><p id="Par3">It has been shown that uremic toxins are capable to induce an inflammatory response in patients with CKD<sup><xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref></sup>. Uremic toxins can cause oxidative stress and stimulate the production of proinflammatory cytokines in this population. Several studies have been reported a relationship between uremic toxins (mainly indoxyl sulfate, p-cresyl sulfate, and indole-3-acetic acid) and inflammation<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. The indoxyl sulfate has been described to activate NF-&#x00138;B, NADPH oxidase, upregulated mRNA and expression of intercellular adhesion molecule-1 (ICAM-1)<sup><xref ref-type="bibr" rid="CR7">7</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref></sup>, and is also capable to induce endothelial injury with the formation of microvesicles that contribute to endothelial cell progenitors dysfunction<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. The p-cresyl sulfate and indole-3-acetic acid are associated with increased IL-6 and CRP, respectively, in patients with CKD<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>.</p><p id="Par4">When renal function deteriorates to &#x0003c;15&#x02009;ml/min/1,73&#x02009;m<sup>2</sup>, patients usually need dialysis support. However, despite the technological advances in the dialysis procedures, thrice weekly conventional hemodialysis is not able to remove all toxins, particularly those too large and/or protein-bounded<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Therefore, patients on dialysis still have serum circulating uremic toxins. Some studies have demonstrated a direct relationship between uremic toxins and inflammation and cardiovascular disease, which is the main cause of mortality in patients with CKD<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>.</p><p id="Par5">Uremic toxins can cause immune activation with production of proinflammatory cytokines including TNF-&#x003b1;, IL-6 and MCP-1<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup> mainly by monocytes<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>. Although these proinflammatory cytokines enhance host defense, their excessive production leads to unresolved inflammation<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. The uremic toxins may induce the toll-like receptor (TLR) activation, resulting in the production of several inflammatory mediators<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Our group has recently reported that TLR4 expression is increased in neutrophils and monocytes obtained from hemodialysis patients that correlated with IL-6, reinforcing the role of TLR4 in the mechanism of inflammation<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>.</p><p id="Par6">Besides cytokines, 25-vitamin D has also been implicated as an inflammatory marker, participating in both innate and adaptive immunity<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Hypovitaminosis D has been often reported in patients with CKD, reaching up to 80% of prevalence<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Although the levels of 1,25-vitamin D are important, it is the circulating concentration of 25-vitamin D that determines the vitamin D status of a given individual. Levels of serum 25-vitamin D from 20 to 60&#x02009;ng/mL are considered normal and values below 20&#x02009;ng/mL are considered indicative of vitamin D deficiency<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>.</p><p id="Par7">The vitamin-D receptor (VDR) and the enzyme 1&#x003b1;-hydroxylase (CYP27) are present in cells of the immune system<sup><xref ref-type="bibr" rid="CR25">25</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref></sup>. 25-vitamin D regulates the expression of cathelicidin, an endogenous antimicrobial peptide<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. This modulation occurs by activation of TLRs, which sign for increased expression of VDR and CYP27, the enzyme that converts 25-vitamin D to the active form, 1,25-vitamin D. This active form regulates the VDR that sign the hCAP18 encoding gene, which is a pro-protein that upon be cleaved releases cathelicidin<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> to act against gram-negative and positive bacteria, viruses and fungi<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>.</p><p id="Par8">Uremic toxins and hypovitaminosis D are important inflammatory markers in patients with CKD. However, few studies evaluated the effect of supplementation of 25-vitamin D on the cells and the mechanisms involved in the innate immunity response. Therefore, the goal of the current study was to evaluate the <italic>in vitro</italic> effect of 25-vitamin D supplementation on inflammation through monocytes cells. The expression of the receptors TLR4, VDR, 1-&#x003b1; hydroxylase, cathelicidin, in addition to oxidative stress and inflammatory cytokines were also evaluated.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Matherial and Methods</title><p id="Par9">Culture assay: The U937 lineage<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> (human monocytic lineage, ATCC #TIB-202) was differentiated into monocytes using phorbol 12-myristate 13- acetate (PMA; Sigma-Aldrich P1585) to evaluate the modulation of 25-vitamin D on the expression of TLR4, VDR, CYP27, CYP24, cathelicidin, IL-6, IL-10, MCP-1, and oxidative stress, as previously described<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. U937 was cultured in RPMI 1640 with (pH 7.4, Sigma Chemical Co., St. Louis, MO, USA), 10&#x02009;mmol/L HEPES (Sigma Chemical Co., St. Louis, MO, NY, USA), 2&#x02009;mmol/L L-Glutamine (Merck, Darmstadt, Germany), 100&#x02009;U/mL penicillin and 100&#x02009;&#x003bc;g/mL streptomycin (Gibco, BRL, Life Technologies, USA), 10% fetal bovine serum and maintained in culture with 5% CO<sub>2</sub> incubator at 37&#x02009;&#x000b0;C.</p><p id="Par10">The culture medium was changed every 48&#x02009;hours until the cell concentration reached 1&#x02009;&#x000d7;&#x02009;10<sup>6</sup>/mL. Subsequently, the cells were stimulated by 10&#x02009;nM/mL PMA for 24&#x02009;hours in a 75&#x02009;cm<sup>3</sup> culture bottle containing 1&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells/mL. After differentiation, the cells were washed in 10&#x02009;mL of PBS (Sigma, Cat P3744-1PAK) to remove the PMA and incubated with 5&#x02009;mL of 0.5% trypsin, in order to detach the cells from the surface of the plaque, obtaining a homogeneous cell suspension. The cells were then washed with culture medium (5&#x02009;mL) for trypsin neutralization, and cell viability testing was performed using Trypan Blue.</p><p id="Par11">After differentiation, U937 cells were transferred to culture bottles of 25&#x02009;cm<sup>2</sup>, preincubated with 25-vitamin D (Sigma-Aldrich CAT: 101443236) at the concentration of 50&#x02009;ng/mL, for 24&#x02009;hs. Afterward, the cells were incubated with serum from uremic patients or serum from healthy subjects. Detailed description of Monoclonal antibodies is shown in Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>.</p><sec id="Sec3"><title>Preparation of human serum pool</title><p id="Par12">Healthy and uremic serum pool were prepared according to our previous study<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>, as follows:</p><p id="Par13"><italic>Healthy Serum Pool</italic>: Blood samples (20&#x02009;mL) were collected from 20 healthy volunteers in tubes with anticoagulants and centrifuged at 500&#x02009;G for 10&#x02009;minutes. The supernatant was stored in freezer aliquots &#x02212;80&#x02009;&#x000b0;C.</p><p id="Par14"><italic>Uremic Serum Pool:</italic> blood samples were collected with anticoagulant tubes from 30 patients in hemodialysis treatment imediately before the begining of the second session of the week. The tubes were centrifuged at 500&#x02009;G for 10&#x02009;minutes. The supernatant was stored in a freezer &#x02212;80&#x02009;&#x000b0;C. Patients that had any type of infection, use of immunosuppressive drugs, vitamin D supplementation, diabetes mellitus or neoplasia disease were excluded from the study.</p><p id="Par15">An aliquot from both sample pools were sent to the laboratory to be sure that uremic pool was representative of uremic environment, detected by the increase of levels of creatinine, urea, parathyroid hormone (PTH), phosphorus and decrease of calcium and 25-vitamin D. Besides, we performed the Limulus amebocyte lysate test (LAL) on both uremic and healthy pool serum to evaluated lipopolysaccharide (LPS) levels, which cause monocyte activation in levels &#x0003e;0.25mlU/mL.</p><p id="Par16">This study was approved by the Institutional Review Board of the Federal University of S&#x000e3;o Paulo (#0727/10). Healthy and uremic serum samples were obtained after written informed consent of participants or legal representative, according to the Helsinki Declaration and local regulations.</p></sec><sec id="Sec4"><title>Expression of CD14, TLR4, VDR, CYP27 and CYP24 by flow cytometry</title><p id="Par17">3&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells from healthy and uremic serum (pre-incubated or not with 25 vitamin D) were used to label monoclonal antibodies to CD14-FITC and TLR4 PE and VDR-APC, CYP27-Alexa Fluor 647 and CYP24-Alexa Fluor 488 (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>) according to manufactures instructions, and was added to healthy and uremic serum pool.</p><p id="Par18">The expression of these monoclonal antibodies was checked by the flow cytometer (FacsCanto I, BD, USA) immediately.</p></sec><sec id="Sec5"><title>Flow cytometry analysis</title><p id="Par19">A forward scatter plot versus side scatter plot was used to make a gate for the U937 cells and to exclude debris. DOT-PLOT graphs were used to analyze the CD14, TLR-4 and VDR (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>) and histograms were used to analyze the CYP27 and CYP24 (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>) and ROS (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref>. The results were described in mean fluorescence intensity (MFI), such that the higher the MFI the greater the expression of these receptors.</p></sec><sec id="Sec6"><title>Detection of reactive oxygen species (ROS) by Flow Cytometry</title><p id="Par20">The 3&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells each condition were transferred into the 12&#x02009;&#x000d7;&#x02009;75&#x02009;mm tube and incubated with 100&#x02009;uL of 2&#x02032;-7&#x02032;-dichlorofluorescein diacetate (DCFH-DA)(FITC) (Sigma, St. Louis, MO, USA) to evaluated ROS, according to previously described<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. The analyses were performed by the flow cytometer (FacsCanto I, BD).</p></sec><sec id="Sec7"><title>Detection of TNF-&#x003b1;, IL-6, IL-10, cathelicidin, MCP-1 by ELISA technique</title><p id="Par21">The culture supernatants were stored at &#x02212;80&#x02009;&#x000b0;C freezer to detection TNF-&#x003b1;, IL-6, IL-10, cathelicidin and MCP-1 by enzyme-linked immunosorbent assay (ELISA) assays. ELISA tests were performed using commercial Kits according to manufacturers&#x02019; instructions (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>).</p></sec><sec id="Sec8"><title>Detection of NF-&#x003ba;B</title><p id="Par22">The monocytes were evaluated for NF-&#x003ba;B activity, according to the manufacturer&#x02019;s instructions (NF-&#x003ba;B p50/p65 Transcription Factor Assay Kit, eBioscience, San Diego, USA). The respective inter- and intra-assay coefficient of variation was 4.1% and 5.9%.</p></sec><sec id="Sec9"><title>Statistical analysis</title><p id="Par23">The results according to each group (healthy, uremic, with 25-vitamin D supplementation and without 25-vitamin D supplementation) were expressed as median (minimum and maximum), and the differences tested by Kruskal Wallis. Relationships between independent variables were performed in the entire group. Kolmogorov-Smirnov test was used to test normality of data. We used Pearson or Spearman correlation coefficient, as appropriate. The value of p&#x02009;&#x0003c;&#x02009;0.05 was considered for statistical significance. The analyses were performed using SPSS (Statistical Package Social Sciences) software version 22.0 for Windows.</p></sec></sec><sec id="Sec10" sec-type="results"><title>Results</title><p id="Par24">Comparison of characteristics between healthy and uremic pool:</p><p id="Par25">Biochemical characteristics: As expected, uremic pool had higher creatinine, urea, PTH, and phosphorus, whereas serum calcium and 25-vitamin D were lower (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Biochemical data from healthy and uremic serum pool.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Healthy Pool</th><th>Uremic Pool</th></tr></thead><tbody><tr><td>Creatinine (mg/dL)</td><td>0.82</td><td>8.92</td></tr><tr><td>Urea (mg/dL)</td><td>33</td><td>135</td></tr><tr><td>PTH (pg/mL)</td><td>23</td><td>392</td></tr><tr><td>Calcium (mg/dL)</td><td>9.7</td><td>7.4</td></tr><tr><td>Phosphorus (mg/dL)</td><td>3.4</td><td>4.3</td></tr><tr><td>25-vitamin D (ng/mL)</td><td>19.2</td><td>10.5</td></tr><tr><td>LPS levels (mlU/mL)</td><td>&#x0003c;0.25</td><td>&#x0003c;0.25</td></tr></tbody></table><table-wrap-foot><p>PTH, parathyroid hormone; LPS, lipopolisaccharide.</p></table-wrap-foot></table-wrap></p><p id="Par26">Inflammatory markers: We observed a higher expression of TRL4, ROS, IL-6, TNF-&#x003b1;, IL-10, cathelicidin, and MCP-1 in monocytes incubated with uremic serum when compared to healthy serum (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). When monocytes were incubated with uremic serum previously treated with 25-vitamin D, there was a reduction in the expression of TLR4, MCP-1, and cathelicidin. There were no differences regarding the expression of VDR, CYP27, CYP24, and NF-&#x003ba;B between groups (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Expression of TLR-4, ROS, VDR, CYP27, CYP24, IL-6, TNF-&#x003b1;, IL-10, cathelicidin, MCP-1 and NF- &#x003ba;B.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="2">Healthy pool (HS)</th><th colspan="2">Uremic pool (US)</th></tr><tr><th>HS</th><th>HS&#x02009;+&#x02009;25 vitamin D</th><th>US</th><th>US&#x02009;+&#x02009;25 vitamin D</th></tr></thead><tbody><tr><td colspan="5"><bold>Expression (MIF)</bold></td></tr><tr><td>TLR4</td><td><p>716</p><p>(654&#x02013;936)</p></td><td><p>644</p><p>(644&#x02013;870)</p></td><td><p>2653*</p><p>(1853&#x02013;3372)</p></td><td><p>1692<sup>&#x02020;</sup></p><p>(1022&#x02013;2292)</p></td></tr><tr><td>ROS</td><td><p>343</p><p>(313&#x02013;498)</p></td><td><p>378</p><p>(320&#x02013;563)</p></td><td><p>550*</p><p>(394&#x02013;607)</p></td><td><p>544</p><p>(435&#x02013;599)</p></td></tr><tr><td>VDR</td><td><p>7882</p><p>(6574&#x02013;9687)</p></td><td><p>8394</p><p>(6475&#x02013;10708)</p></td><td><p>7657</p><p>(6670&#x02013;9420)</p></td><td><p>7556</p><p>(5699&#x02013;9420)</p></td></tr><tr><td>CYP27</td><td><p>1201</p><p>(692&#x02013;1461)</p></td><td><p>1207</p><p>(747&#x02013;1521)</p></td><td><p>1396</p><p>(931&#x02013;1532)</p></td><td><p>1170</p><p>(955&#x02013;1521)</p></td></tr><tr><td>CYP24</td><td><p>439</p><p>(319&#x02013;563)</p></td><td><p>363</p><p>(329&#x02013;501)</p></td><td><p>342</p><p>(331&#x02013;676)</p></td><td><p>375</p><p>(333&#x02013;485)</p></td></tr><tr><td colspan="5"><bold>Cytokines (pg/mL)</bold></td></tr><tr><td>IL-6</td><td><p>3.8</p><p>(3.3&#x02013;4.9)</p></td><td><p>3.6</p><p>(3.1&#x02013;5.3)</p></td><td><p>39.3*</p><p>(28.3&#x02013;45.3)</p></td><td><p>37.3</p><p>(28.8&#x02013;42.5)</p></td></tr><tr><td>TNF-&#x003b1;</td><td><p>2.2</p><p>(1.6&#x02013;2.7)</p></td><td><p>2.3</p><p>(2.1&#x02013;3.2)</p></td><td><p>3.9*</p><p>(3.2&#x02013;4.7)</p></td><td><p>3.4</p><p>(2.9&#x02013;4.8)</p></td></tr><tr><td>IL-10</td><td><p>45</p><p>(41&#x02013;62)</p></td><td><p>47</p><p>(45&#x02013;62)</p></td><td><p>61*</p><p>(53&#x02013;64)</p></td><td><p>60</p><p>(56&#x02013;73)</p></td></tr><tr><td>CATHELICIDIN</td><td><p>0.44</p><p>(0.43&#x02013;0.46)</p></td><td><p>0.43</p><p>(0.4&#x02013;0.49)</p></td><td><p>0.58*</p><p>(0.51&#x02013;0.65)</p></td><td><p>0.52<sup>&#x02020;</sup></p><p>(0.48&#x02013;0.59)</p></td></tr><tr><td>MCP-1</td><td><p>11076</p><p>(7899&#x02013;11948)</p></td><td><p>7336</p><p>(4820&#x02013;8905)</p></td><td><p>14370*</p><p>(9117&#x02013;16936)</p></td><td><p>7697<sup>&#x02020;</sup></p><p>(5940&#x02013;10310)</p></td></tr><tr><td>NF- &#x003ba;B (%)</td><td><p>4.8</p><p>(1.6&#x02013;1.2)</p></td><td><p>3.1</p><p>(1.7&#x02013;3.4)</p></td><td><p>3.4</p><p>(2.1&#x02013;5.5)</p></td><td><p>4.1</p><p>(2.3&#x02013;6.4)</p></td></tr></tbody></table><table-wrap-foot><p>*US &#x02260; HS: p&#x02009;&#x0003c;&#x02009;0.04.</p><p><sup>&#x02020;</sup>US&#x02009;+&#x02009;25 vitamin D &#x02260; US: p&#x02009;&#x0003c;&#x02009;0.03.</p></table-wrap-foot></table-wrap></p><p id="Par27">Correlations among inflammatory markers: We performed correlation between TLR4 and other variables to address the interplay among this receptor and inflammatory markers. In fact, there was a positive correlation between the expression of TLR4 and ROS, IL-6, TNF-&#x003b1; and IL-10, MCP-1 and cathelicidin (all p values&#x02009;&#x0003c;&#x02009;0.05). There was also a positive correlation between IL-6 with ROS, IL-10, cathelicidin and MCP-1, a positive correlation between TNF-&#x003b1; and ROS, IL-10, cathelicidin and MCP-1, and between cathelicidin and ROS, IL-10 and MCP-1 (all p values&#x02009;&#x0003c;&#x02009;0.05). These correlations are illustrated in Figs.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref>, <xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p>Correlation between TLR-4 and ROS, IL-6, TNF-&#x003b1;, IL-10, cathelicidin and MCP-1.</p></caption><graphic xlink:href="41598_2019_56874_Fig1_HTML" id="d29e967"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>Correlation between expression of IL-6 and ROS, TNF-&#x003b1;, IL-10, Cathelicidin and MCP-1.</p></caption><graphic xlink:href="41598_2019_56874_Fig2_HTML" id="d29e976"/></fig><fig id="Fig3"><label>Figure 3</label><caption><p>Correlation between expression of TNF-&#x003b1; and ROS, IL-10, cathelicidin and MCP-1.</p></caption><graphic xlink:href="41598_2019_56874_Fig3_HTML" id="d29e986"/></fig><fig id="Fig4"><label>Figure 4</label><caption><p>Correlation between expression of Cathelicidin and ROS, IL-10 and MCP-1.</p></caption><graphic xlink:href="41598_2019_56874_Fig4_HTML" id="d29e995"/></fig></p></sec><sec id="Sec11" sec-type="discussion"><title>Discussion</title><p id="Par28">In this study, we confirmed that the uremic environment is associated with an inflammatory status, which was depicted by elevated levels of cytokines and ROS. In addition, uremic serum, similarly to what happens in patients with CKD presented low levels of 25-vitamin D. The novelty of our study, however, was demonstrating that 25-vitamin D was capable to reduce TLR-4, MCP-1, and cathelicidin in a uremic environment. Taken together, our findings provide evidence that vitamin D has a role in protecting against inflammation, at least mediated by monocytes.</p><p id="Par29">The high TLR4 expression is important to improve the infection response, however the continuous expression leads to a release of pro-inflammatory cytokines. We observed a high expression of TLR4 in monocytes incubated with uremic serum compared with healthy serum and a positive association with cytokines and ROS. The TLR4 expression may activate the intracellular nuclear factor-&#x003ba;B (NF-&#x003ba;B) pathway and enhances the expression of NF-&#x003ba;B-controlled genes such as for inflammatory cytokines and adhesion molecules not only in monocytes but also in endothelial cells<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. In our <italic>in vitro</italic> study, we did not observe a difference in the percentage of NF-&#x003ba;B, despite the overexpression of TLR4 in monocytes incubated with uremic serum.</p><p id="Par30">The short-time incubation could lead to this contradictory result, although our results are similar to a previous study that did not show an effect of a 16-week supplementation of vitamin D on NF-&#x003ba;B activity<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. TLR4, however, associated with cytokines, confirming previous studies<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup> in patients on hemodialysis.</p><p id="Par31">We observed an increased production and secretion of ROS and MCP-1 in monocytes incubated with uremic serum compared to healthy serum. The Monocyte chemoattractant peptide protein 1 (MCP-1) has been described to attract circulating cells from blood vessels to the local injury sites and together with inflammatory mediators and ROS may contribute to the increased vascular injury<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> and also cardiovascular disease in patients with CKD<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. The relationship between uremia and the vascular lesion has been demonstrated by Stinghen A <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>, describing in an <italic>in vitro</italic> study that indoxyl sulfate, a uremic toxin, causes endothelial lesion that may contribute to cardiovascular disease in patients with CKD.</p><p id="Par32">The supplementation of 25-vitamin D, tested in the current study as an anti-inflammatory agent, seems to have an effect on monocytes. The lower TLR4 expression suggests a downregulation effect of 25-vitamin D on this receptor. Recently, Zhang Y <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> described a beneficial effect of 25-vitamin D supplementation on the decrease of IL-6 and TNF-&#x003b1;, though this study was conducted in patients without renal disease. We found no effect of the 25-vitamin D supplementation downregulating cytokines that might be related to the short period of treatment (24-hour).</p><p id="Par33">The 25-vitamin D decreased MCP-1 in monocytes incubated with uremic serum. We expected that low levels of MCP-1 would result in fewer leukocytes recruitment and endothelial injury. Cathelicidin is an endogenous antimicrobial peptide<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> that also works as an inflammatory marker<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. In the current study, we showed a positive correlation of cathelicidin with IL-6 and TNF-&#x003b1;, reinforcing this hypothesis.</p><p id="Par34">Giffoni <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> demonstrated that lymphocytes obtained from uremic patients supplemented with 25-vitamin D exhibited an increase of VDR and CYP27 expression, resulting in reduced production of pro-inflammatory cytokines. Contrary to expectations, we did not observe an increased intracellular expression of VDR and CYP27 when the monocytes were treated with 25-vitamin D. It supposed that the effect of 25-vitamin D might be dependent on the cell type and exposure time to regulate inflammatory mechanisms.</p><p id="Par35">Our study has some limitations such as the short time of follow-up and the lack of gene expression evaluation, which could help to elucidate the mechanism of anti-inflammatory effect of vitamin D. The strength of our study was to demonstrate the effect of 25-vitamin D in TLR4, cathelicidin and MCP-1 expressions suggesting that this pre-activated form of vitamin D may minimize inflammation. Whether the supplementation of 25-vitamin D in patients with CKD is capable to reduce inflammation needs to be confirmed in further studies.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec12"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2019_56874_MOESM1_ESM.docx"><caption><p>Supplementary Information&#x000a0;</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p>is available for this paper at 10.1038/s41598-019-56874-1.</p></sec><ack><title>Acknowledgements</title><p>The authors thank all the professionals who provided essential technical support during the conduction of this work. This work was supported by Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo, FAPESP (Grant Number 2014-14192-1).</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Study design, data collection, flow cytometry data acquisition, analysis, interpretation, and approval of the final version of the article: Brito, R.; Rebello J.F.; ELISA data acquisition, analysis and interpretation, signifcant intellectual insights, approval of the final version of the article: Grabulosa, C.C.; Bioinformatics analysis, interpretation and significant intellectual insights, approval of the final version of the article: Pinto, W. and Morales, A. Bioinformatics analysis, interpretation and significant intellectual insights and review and approval of the final version of the article, approval of the final version of the article: Elias, R.M. and Moys&#x000e9;s, R.M.; Study design, data analysis, interpretation, intellectual insights, manuscript writing, review, and approval of the final version of the article, approval of the final version of the article: Dalboni, M.A.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par36">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanholder</surname><given-names>RC</given-names></name><name><surname>Glorieux</surname><given-names>GL</given-names></name></person-group><article-title>An overview of uremic toxicity. Hemodialysis international</article-title><source>International Symposium on Home Hemodialysis</source><year>2003</year><volume>7</volume><fpage>156</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1046/j.1492-7535.2003.00034.x</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borges</surname><given-names>NA</given-names></name><etal/></person-group><article-title>Protein-Bound Uremic Toxins from Gut Microbiota and Inflammatory Markers in Chronic Kidney Disease</article-title><source>Journal of renal nutrition: the official journal of the Council on Renal Nutrition of the National Kidney Foundation</source><year>2016</year><volume>26</volume><fpage>396</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1053/j.jrn.2016.07.005</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease</article-title><source>Archives of medical research</source><year>2014</year><volume>45</volume><fpage>309</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/j.arcmed.2014.04.002</pub-id><pub-id pub-id-type="pmid">24751327</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaminski</surname><given-names>TW</given-names></name><name><surname>Pawlak</surname><given-names>K</given-names></name><name><surname>Karbowska</surname><given-names>M</given-names></name><name><surname>Mysliwiec</surname><given-names>M</given-names></name><name><surname>Pawlak</surname><given-names>D</given-names></name></person-group><article-title>Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease</article-title><source>BMC nephrology</source><year>2017</year><volume>18</volume><fpage>35</fpage><pub-id pub-id-type="doi">10.1186/s12882-017-0457-1</pub-id><pub-id pub-id-type="pmid">28122514</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onal</surname><given-names>EM</given-names></name><name><surname>Afsar</surname><given-names>B</given-names></name><name><surname>Covic</surname><given-names>A</given-names></name><name><surname>Vaziri</surname><given-names>ND</given-names></name><name><surname>Kanbay</surname><given-names>M</given-names></name></person-group><article-title>Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease</article-title><source>Hypertension research: official journal of the Japanese Society of Hypertension</source><year>2019</year><volume>42</volume><fpage>123</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/s41440-018-0144-z</pub-id><pub-id pub-id-type="pmid">30504819</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>WL</given-names></name><name><surname>Savoj</surname><given-names>J</given-names></name><name><surname>Nakata</surname><given-names>MB</given-names></name><name><surname>Vaziri</surname><given-names>ND</given-names></name></person-group><article-title>Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins</article-title><source>Clinical science</source><year>2018</year><volume>132</volume><fpage>509</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1042/CS20171107</pub-id><pub-id pub-id-type="pmid">29523750</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolati</surname><given-names>D</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Yisireyili</surname><given-names>M</given-names></name><name><surname>Nishijima</surname><given-names>F</given-names></name><name><surname>Niwa</surname><given-names>T</given-names></name></person-group><article-title>Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-kappaB</article-title><source>BMC nephrology</source><year>2013</year><volume>14</volume><fpage>56</fpage><pub-id pub-id-type="doi">10.1186/1471-2369-14-56</pub-id><pub-id pub-id-type="pmid">23496811</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockler-Pinto</surname><given-names>MB</given-names></name><etal/></person-group><article-title>From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-kappaB/Nrf2 expression</article-title><source>International urology and nephrology</source><year>2018</year><volume>50</volume><fpage>347</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1007/s11255-017-1748-y</pub-id><pub-id pub-id-type="pmid">29151180</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Yisireyili</surname><given-names>M</given-names></name><name><surname>Higashiyama</surname><given-names>Y</given-names></name><name><surname>Nishijima</surname><given-names>F</given-names></name><name><surname>Niwa</surname><given-names>T</given-names></name></person-group><article-title>Indoxyl sulfate upregulates renal expression of ICAM-1 via production of ROS and activation of NF-kappaB and p53 in proximal tubular cells</article-title><source>Life sciences</source><year>2013</year><volume>92</volume><fpage>143</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2012.11.012</pub-id><pub-id pub-id-type="pmid">23201429</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmona</surname><given-names>A</given-names></name><etal/></person-group><article-title>Microvesicles Derived from Indoxyl Sulfate Treated Endothelial Cells Induce Endothelial Progenitor Cells Dysfunction</article-title><source>Frontiers in physiology</source><year>2017</year><volume>8</volume><fpage>666</fpage><pub-id pub-id-type="doi">10.3389/fphys.2017.00666</pub-id><pub-id pub-id-type="pmid">28951723</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azevedo</surname><given-names>ML</given-names></name><etal/></person-group><article-title>p-Cresyl sulfate affects the oxidative burst, phagocytosis process, and antigen presentation of monocyte-derived macrophages</article-title><source>Toxicology letters</source><year>2016</year><volume>263</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2016.10.006</pub-id><pub-id pub-id-type="pmid">27760375</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claro</surname><given-names>Ligia</given-names></name><name><surname>Moreno-Amaral</surname><given-names>Andrea</given-names></name><name><surname>Gadotti</surname><given-names>Ana</given-names></name><name><surname>Dolenga</surname><given-names>Carla</given-names></name><name><surname>Nakao</surname><given-names>Lia</given-names></name><name><surname>Azevedo</surname><given-names>Marina</given-names></name><name><surname>de Noronha</surname><given-names>Lucia</given-names></name><name><surname>Olandoski</surname><given-names>Marcia</given-names></name><name><surname>de Moraes</surname><given-names>Thyago</given-names></name><name><surname>Stinghen</surname><given-names>Andr&#x000e9;a</given-names></name><name><surname>P&#x000e9;coits-Filho</surname><given-names>Roberto</given-names></name></person-group><article-title>The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease</article-title><source>Toxins</source><year>2018</year><volume>10</volume><issue>10</issue><fpage>384</fpage><pub-id pub-id-type="doi">10.3390/toxins10100384</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Chertow</surname><given-names>GM</given-names></name><name><surname>Fan</surname><given-names>D</given-names></name><name><surname>McCulloch</surname><given-names>CE</given-names></name><name><surname>Hsu</surname><given-names>CY</given-names></name></person-group><article-title>Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization</article-title><source>The New England journal of medicine</source><year>2004</year><volume>351</volume><fpage>1296</fpage><lpage>1305</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa041031</pub-id><pub-id pub-id-type="pmid">15385656</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lekawanvijit</surname><given-names>S</given-names></name><name><surname>Krum</surname><given-names>H</given-names></name></person-group><article-title>Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins</article-title><source>The Journal of physiology</source><year>2014</year><volume>592</volume><fpage>3969</fpage><lpage>3983</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2014.273078</pub-id><pub-id pub-id-type="pmid">24907309</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kracht</surname><given-names>M</given-names></name><name><surname>Saklatvala</surname><given-names>J</given-names></name></person-group><article-title>Transcriptional and post-transcriptional control of gene expression in inflammation</article-title><source>Cytokine</source><year>2002</year><volume>20</volume><fpage>91</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1006/cyto.2002.0895</pub-id><pub-id pub-id-type="pmid">12453467</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhavsar</surname><given-names>P</given-names></name><etal/></person-group><article-title>Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma</article-title><source>Thorax</source><year>2008</year><volume>63</volume><fpage>784</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1136/thx.2007.090027</pub-id><pub-id pub-id-type="pmid">18492738</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HY</given-names></name><etal/></person-group><article-title>Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD)</article-title><source>Scientific reports</source><year>2017</year><volume>7</volume><fpage>3057</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-03130-z</pub-id><pub-id pub-id-type="pmid">28596556</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trojanowicz</surname><given-names>B</given-names></name><name><surname>Ulrich</surname><given-names>C</given-names></name><name><surname>Seibert</surname><given-names>E</given-names></name><name><surname>Fiedler</surname><given-names>R</given-names></name><name><surname>Girndt</surname><given-names>M</given-names></name></person-group><article-title>Uremic conditions drive human monocytes to pro-atherogenic differentiation via an angiotensin-dependent mechanism</article-title><source>PloS one</source><year>2014</year><volume>9</volume><fpage>e102137</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0102137</pub-id><pub-id pub-id-type="pmid">25003524</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrillo</surname><given-names>JE</given-names></name></person-group><article-title>Pathogenetic mechanisms of septic shock</article-title><source>The New England journal of medicine</source><year>1993</year><volume>328</volume><fpage>1471</fpage><lpage>1477</lpage><pub-id pub-id-type="doi">10.1056/NEJM199305203282008</pub-id><pub-id pub-id-type="pmid">8479467</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charytan</surname><given-names>DM</given-names></name><name><surname>Fishbane</surname><given-names>S</given-names></name><name><surname>Malyszko</surname><given-names>J</given-names></name><name><surname>McCullough</surname><given-names>PA</given-names></name><name><surname>Goldsmith</surname><given-names>D</given-names></name></person-group><article-title>Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia</article-title><source>American journal of kidney diseases: the official journal of the National Kidney Foundation</source><year>2015</year><volume>66</volume><fpage>196</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2014.12.016</pub-id><pub-id pub-id-type="pmid">25727384</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabulosa</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Chronic kidney disease induces inflammation by increasing Toll-like receptor-4, cytokine and cathelicidin expression in neutrophils and monocytes</article-title><source>Experimental cell research</source><year>2018</year><volume>365</volume><fpage>157</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2018.02.022</pub-id><pub-id pub-id-type="pmid">29481790</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holick</surname><given-names>MF</given-names></name></person-group><article-title>Vitamin D deficiency</article-title><source>The New England journal of medicine</source><year>2007</year><volume>357</volume><fpage>266</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1056/NEJMra070553</pub-id><pub-id pub-id-type="pmid">17634462</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franca Gois</surname><given-names>Pedro</given-names></name><name><surname>Wolley</surname><given-names>Martin</given-names></name><name><surname>Ranganathan</surname><given-names>Dwarakanathan</given-names></name><name><surname>Seguro</surname><given-names>Antonio</given-names></name></person-group><article-title>Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies</article-title><source>International Journal of Environmental Research and Public Health</source><year>2018</year><volume>15</volume><issue>8</issue><fpage>1773</fpage><pub-id pub-id-type="doi">10.3390/ijerph15081773</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holick</surname><given-names>MF</given-names></name></person-group><article-title>The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention</article-title><source>Reviews in endocrine &#x00026; metabolic disorders</source><year>2017</year><volume>18</volume><fpage>153</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1007/s11154-017-9424-1</pub-id><pub-id pub-id-type="pmid">28516265</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhalla</surname><given-names>AK</given-names></name><name><surname>Amento</surname><given-names>EP</given-names></name><name><surname>Clemens</surname><given-names>TL</given-names></name><name><surname>Holick</surname><given-names>MF</given-names></name><name><surname>Krane</surname><given-names>SM</given-names></name></person-group><article-title>Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation</article-title><source>The Journal of clinical endocrinology and metabolism</source><year>1983</year><volume>57</volume><fpage>1308</fpage><lpage>1310</lpage><pub-id pub-id-type="doi">10.1210/jcem-57-6-1308</pub-id><pub-id pub-id-type="pmid">6313738</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stumpf</surname><given-names>WE</given-names></name><name><surname>Sar</surname><given-names>M</given-names></name><name><surname>Reid</surname><given-names>FA</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>DeLuca</surname><given-names>HF</given-names></name></person-group><article-title>Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid</article-title><source>Science</source><year>1979</year><volume>206</volume><fpage>1188</fpage><lpage>1190</lpage><pub-id pub-id-type="doi">10.1126/science.505004</pub-id><pub-id pub-id-type="pmid">505004</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gombart</surname><given-names>AF</given-names></name><name><surname>O&#x02019;Kelly</surname><given-names>J</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Koeffler</surname><given-names>HP</given-names></name></person-group><article-title>Regulation of the CAMP gene by 1,25(OH)2D3 in various tissues</article-title><source>The Journal of steroid biochemistry and molecular biology</source><year>2007</year><volume>103</volume><fpage>552</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1016/j.jsbmb.2006.12.095</pub-id><pub-id pub-id-type="pmid">17368184</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>PT</given-names></name><etal/></person-group><article-title>Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response</article-title><source>Science</source><year>2006</year><volume>311</volume><fpage>1770</fpage><lpage>1773</lpage><pub-id pub-id-type="doi">10.1126/science.1123933</pub-id><pub-id pub-id-type="pmid">16497887</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorensen</surname><given-names>OE</given-names></name><etal/></person-group><article-title>Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3</article-title><source>Blood</source><year>2001</year><volume>97</volume><fpage>3951</fpage><lpage>3959</lpage><pub-id pub-id-type="doi">10.1182/blood.V97.12.3951</pub-id><pub-id pub-id-type="pmid">11389039</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramanathan</surname><given-names>B</given-names></name><name><surname>Davis</surname><given-names>EG</given-names></name><name><surname>Ross</surname><given-names>CR</given-names></name><name><surname>Blecha</surname><given-names>F</given-names></name></person-group><article-title>Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity</article-title><source>Microbes and infection</source><year>2002</year><volume>4</volume><fpage>361</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1016/S1286-4579(02)01549-6</pub-id><pub-id pub-id-type="pmid">11909747</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>SK</given-names></name><name><surname>Micinski</surname><given-names>D</given-names></name></person-group><article-title>Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes</article-title><source>Biochemical and biophysical research communications</source><year>2013</year><volume>437</volume><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2013.06.004</pub-id><pub-id pub-id-type="pmid">23770363</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Dai</surname><given-names>F</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Le</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>W</given-names></name></person-group><article-title>Macrophage differentiation induced by PMA is mediated by activation of RhoA/ROCK signaling</article-title><source>The Journal of toxicological sciences</source><year>2017</year><volume>42</volume><fpage>763</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.2131/jts.42.763</pub-id><pub-id pub-id-type="pmid">29142175</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>JTG</given-names></name><etal/></person-group><article-title>Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial</article-title><source>PloS one</source><year>2017</year><volume>12</volume><fpage>e0179540</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0179540</pub-id><pub-id pub-id-type="pmid">28665937</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasui</surname><given-names>M</given-names></name><name><surname>Hirabayashi</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name></person-group><article-title>Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood</article-title><source>Journal of immunological methods</source><year>1989</year><volume>117</volume><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(89)90118-X</pub-id><pub-id pub-id-type="pmid">2913161</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name></person-group><article-title>Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity</article-title><source>The Journal of clinical investigation</source><year>2001</year><volume>107</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1172/JCI11837</pub-id><pub-id pub-id-type="pmid">11134172</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name></person-group><article-title>Toll-like receptor signalling</article-title><source>Nature reviews. Immunology</source><year>2004</year><volume>4</volume><fpage>499</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1038/nri1391</pub-id><pub-id pub-id-type="pmid">15229469</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mousa</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial</article-title><source>Scientific reports</source><year>2017</year><volume>7</volume><fpage>15154</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-15264-1</pub-id><pub-id pub-id-type="pmid">29123173</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meireles</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: A randomized controlled trial</article-title><source>Clinical nutrition</source><year>2016</year><volume>35</volume><fpage>1251</fpage><lpage>1258</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2016.04.014</pub-id><pub-id pub-id-type="pmid">27161894</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Outtz</surname><given-names>HH</given-names></name><name><surname>Wu</surname><given-names>JK</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Kitajewski</surname><given-names>J</given-names></name></person-group><article-title>Notch1 deficiency results in decreased inflammation during wound healing and regulates vascular endothelial growth factor receptor-1 and inflammatory cytokine expression in macrophages</article-title><source>Journal of immunology</source><year>2010</year><volume>185</volume><fpage>4363</fpage><lpage>4373</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1000720</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukami</surname><given-names>A</given-names></name><etal/></person-group><article-title>High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population</article-title><source>Clinical cardiology</source><year>2011</year><volume>34</volume><fpage>189</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1002/clc.20834</pub-id><pub-id pub-id-type="pmid">21337348</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stinghen</surname><given-names>AE</given-names></name><name><surname>Pecoits-Filho</surname><given-names>R</given-names></name></person-group><article-title>Vascular damage in kidney disease: beyond hypertension</article-title><source>International journal of hypertension</source><year>2011</year><volume>2011</volume><fpage>232683</fpage><pub-id pub-id-type="doi">10.4061/2011/232683</pub-id><pub-id pub-id-type="pmid">21876786</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1</article-title><source>Journal of immunology</source><year>2012</year><volume>188</volume><fpage>2127</fpage><lpage>2135</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1102412</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinheiro da Silva</surname><given-names>F</given-names></name><name><surname>Machado</surname><given-names>MC</given-names></name></person-group><article-title>The dual role of cathelicidins in systemic inflammation</article-title><source>Immunology letters</source><year>2017</year><volume>182</volume><fpage>57</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2017.01.004</pub-id><pub-id pub-id-type="pmid">28082134</pub-id></element-citation></ref></ref-list></back></article>